Cargando…
Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids
OBJECTIVE: To develop prediction models for individual patient harm and benefit outcomes in elderly patients with RA and comorbidities treated with chronic low-dose glucocorticoid therapy or placebo. METHODS: In the Glucocorticoid Low-dose Outcome in Rheumatoid Arthritis (GLORIA) study, 451 RA patie...
Autores principales: | Hartman, Linda, da Silva, José A P, Buttgereit, Frank, Cutolo, Maurizio, Opris-Belinski, Daniela, Szekanecz, Zoltan, Masaryk, Pavol, Voshaar, Marieke J H, Heymans, Martijn W, Lems, Willem F, van der Heijde, Désirée M F M, Boers, Maarten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152289/ https://www.ncbi.nlm.nih.gov/pubmed/36165675 http://dx.doi.org/10.1093/rheumatology/keac547 |
Ejemplares similares
-
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial
por: Boers, Maarten, et al.
Publicado: (2022) -
Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial
por: Hartman, Linda, et al.
Publicado: (2018) -
Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count
por: Hartman, Linda, et al.
Publicado: (2021) -
Outcome measures for adherence data from a medication event monitoring system: A literature review
por: Hartman, Linda, et al.
Publicado: (2018) -
Glucocorticoids: bad or safe for the bones?
por: Lems, Willem F
Publicado: (2015)